Browse Pet Safety Reports
34,351 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 34,351 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product, widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 34,351 FDA veterinary adverse event reports.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Nov 1, 2024 | Dog | Retriever - Labrador | Moxidectin | Seizure NOS | Recovered/Normal |
| Nov 1, 2024 | Dog | Great Pyrenees, Dog (unknown) | Oclacitinib Maleate | Seizure NOS | Ongoing |
| Nov 1, 2024 | Dog | Retriever - Labrador | Bedinvetmab | Not eating; Weight loss; Not drinking; Dry skin; Panting; Dry heaving; Seizur... | Ongoing |
| Nov 1, 2024 | Dog | Terrier - Yorkshire | Oclacitinib Maleate | Lack of efficacy - NOS; Skin lump; Erythema (for urticaria see Immune SOC); P... | Outcome Unknown |
| Nov 1, 2024 | Dog | Terrier - Irish Soft-coated... | Bedinvetmab | Seizure NOS; Urinary incontinence; Vomiting; Diarrhoea; Shaking; Panting | Outcome Unknown |
| Nov 1, 2024 | Dog | Spaniel - American Water | Pyrantel Pamoate;Sarolaner | Lethargy (see also Central nervous system depression in Neurological); Seizur... | Euthanized |
| Nov 1, 2024 | Dog | Schipperke | Imidacloprid; Moxidectin | Foaming at the mouth; Clenched jaw; Seizure NOS; Thrombocytopenia; Other abno... | Outcome Unknown |
| Nov 1, 2024 | Dog | Dog (unknown) | Phenylpropanolamine Hydrochloride | Seizure NOS; Encephalitis; Meningitis | Outcome Unknown |
| Nov 1, 2024 | Dog | Dog (unknown) | Meloxicam | Seizure NOS; Itching | Outcome Unknown |
| Nov 1, 2024 | Dog | Dachshund - Standard Long-h... | Pyrantel Pamoate;Sarolaner | Seizure NOS; Coma; Unresponsive to stimuli | Recovered/Normal |
| Nov 1, 2024 | Dog | Beagle, Terrier - Rat | Pyrantel Pamoate;Sarolaner | Seizure NOS | Ongoing |
| Nov 1, 2024 | Dog | Retriever - Labrador, Dog (... | Pyrantel Pamoate;Sarolaner | General illness; Limping; Arthritis; Pain NOS; Falling; Inappropriate urinati... | Died |
| Oct 31, 2024 | Dog | Shepherd Dog - German | Afoxolaner 150Mg / Moxidectin 720Mcg ... | Lethargy (see also Central nervous system depression in Neurological); Not hi... | Outcome Unknown |
| Oct 31, 2024 | Dog | Hound (unspecified) | Propofol | Seizure NOS | Recovered/Normal |
| Oct 31, 2024 | Dog | Sheepdog - Shetland | Afoxolaner 37.5Mg / Moxidectin 180Mcg... | Seizure NOS | Recovered/Normal |
| Oct 31, 2024 | Cat | Domestic Shorthair | Robenacoxib | Seizure NOS | Outcome Unknown |
| Oct 31, 2024 | Cat | Maine Coon | Eprinomectin; Praziquantel; Esafoxolaner | Ataxia; Tongue protrusion; Seizure NOS; Behavioural disorder NOS; Agitation; ... | Outcome Unknown |
| Oct 31, 2024 | Dog | Retriever - Golden, Mixed (... | Bedinvetmab | Congestive heart failure; Breathing difficulty; Seizure NOS; Death | Died |
| Oct 31, 2024 | Dog | Spitz - German Pomeranian | Pyrantel Pamoate;Sarolaner | Seizure NOS | Ongoing |
| Oct 30, 2024 | Dog | Maltese, Poodle - Miniature | Trilostane | Elevated serum alkaline phosphatase (ALP); Seizure NOS; Hypocortisolaemia; Ab... | Outcome Unknown |
| Oct 30, 2024 | Dog | Bulldog - French | Moxidectin | Grand mal seizure | Ongoing |
| Oct 30, 2024 | Dog | Rottweiler | Nitenpyram | Increased seizure frequency | Outcome Unknown |
| Oct 30, 2024 | Dog | Retriever - Labrador, Dog (... | Pyrantel Pamoate;Sarolaner | Seizure NOS | Ongoing |
| Oct 30, 2024 | Dog | Crossbred Canine/dog, Retri... | Fluralaner 13.64% 12-Week Chew | Muscle pain; Seizure NOS; Tremor; Decreased appetite; Pain NOS; Behavioural d... | Ongoing |
| Oct 30, 2024 | Dog | Terrier - Yorkshire | Fluralaner 13.64% 12-Week Chew | Seizure NOS; Shaking; Lateral recumbency; Vomiting; Distension of abdomen | Recovered/Normal |
| Oct 30, 2024 | Dog | Terrier - Boston | Moxidectin | Seizure NOS | Recovered/Normal |
| Oct 30, 2024 | Dog | Crossbred Canine/dog | Moxidectin | Grand mal seizure | Recovered/Normal |
| Oct 30, 2024 | Dog | Chihuahua | Ivermectin; Pyrantel As Pamoate Salt | Seizure NOS | Outcome Unknown |
| Oct 30, 2024 | Dog | Retriever - Labrador | Pyrantel Pamoate;Sarolaner | Seizure NOS; Head tremor; Vocalisation; Gait abnormality | Ongoing |
| Oct 29, 2024 | Dog | Siberian Husky | Bedinvetmab | Seizure NOS | Ongoing |
| Oct 29, 2024 | Dog | Dalmatian | Carprofen | Vomiting; Diarrhoea; Paralysis NOS; Shaking; Head bobbing; Seizure NOS | Recovered/Normal |
| Oct 29, 2024 | Dog | Terrier - Bull - American Pit | Bedinvetmab | Seizure NOS | Recovered/Normal |
| Oct 29, 2024 | Dog | Siberian Husky | Sarolaner | Seizure NOS | Outcome Unknown |
| Oct 29, 2024 | Dog | Shepherd Dog - German | Propofol | Seizure NOS | Outcome Unknown |
| Oct 28, 2024 | Dog | Spaniel (unspecified) | Dimethyl Sulfoxide;Fluocinolone Aceto... | Shaking; Bloody diarrhoea; Not eating; Lethargy (see also Central nervous sys... | Outcome Unknown |
| Oct 28, 2024 | Dog | Retriever - Labrador | Afoxolaner | Seizure NOS; Ataxia; Loss of bowel control; Stiffness NOS | Recovered/Normal |
| Oct 28, 2024 | Dog | Shiba Inu | Afoxolaner | Seizure NOS | Outcome Unknown |
| Oct 28, 2024 | Dog | Retriever - Labrador, Dog (... | Bedinvetmab | Grand mal seizure; Hypoglycaemia; Hepatic tumour; Elevated alanine aminotrans... | Euthanized |
| Oct 28, 2024 | Dog | Terrier - Bull - American Pit | Bedinvetmab | Gagging; Vomiting; Seizure NOS; Musculoskeletal disorder NOS | Ongoing |
| Oct 28, 2024 | Dog | Chihuahua | Afoxolaner | Seizure NOS; Dilated pupils; Shaking; Behavioural disorder NOS | Ongoing |
| Oct 28, 2024 | Dog | Shih Tzu | Fluralaner 13.64% 12-Week Chew | Nervous; Vocalisation; Panting; Agitation; Lying down; Twitching; Seizure NOS | Recovered/Normal |
| Oct 27, 2024 | Dog | Spaniel - Springer English | Selamectin | Seizure NOS | Recovered/Normal |
| Oct 26, 2024 | Dog | Mixed (Dog) | Bedinvetmab | Seizure NOS | Outcome Unknown |
| Oct 26, 2024 | Dog | Siberian Husky | Bedinvetmab | Seizure NOS | Ongoing |
| Oct 26, 2024 | Dog | Beagle, Dog (unknown) | Pimobendan | Skin lesion NOS; Vomiting; Lethargy (see also Central nervous system depressi... | Ongoing |
| Oct 26, 2024 | Dog | Dog (unknown) | Bedinvetmab | Seizure NOS | Ongoing |
| Oct 26, 2024 | Cat | Domestic Shorthair | Marbofloxacin | Focal seizure; Vomiting | Ongoing |
| Oct 26, 2024 | Dog | Beagle, Dog (unknown) | Cefovecin | Skin lesion NOS; Vomiting; Lethargy (see also Central nervous system depressi... | Ongoing |
| Oct 26, 2024 | Dog | Retriever - Labrador, Dog (... | Propofol | Seizure NOS; Tremor | Recovered/Normal |
| Oct 26, 2024 | Dog | Retriever - Labrador | Isoflurane | Seizure NOS; Tremor | Recovered/Normal |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe, difficulty breathing, seizures, collapse, or severe swelling, seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.